((自动化翻译由路透提供，请见免责声明 ))
11月7日 - ** 疫苗制造商 莫德纳 股价盘前上涨 10%，至 57 美元
** 由于 COVID 疫苗销售额高于预期，该公司公布的 (link) 第三季度利润令人吃惊
** 公司本季度盈利 1300 万美元，合每股 3 美分，而去年同期亏损 36 亿美元。
** 根据 LSEG 统计的数据，分析师此前预计公司将亏损 7.53 亿美元，合每股亏损 1.90 美元。
** 莫德纳 公司的 Spikevax COVID 疫苗销售额达 18 亿美元，超过预期的 13.8 亿美元。
** 截至上次收盘，股价年累计下跌约 48
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.